U.S. Market for IV Therapy and Vein Access

Published - Aug 2006| Analyst - Mary Anne Crandall| Code - HLC046A
Market Research Report Single User License: $2750 Member Price: FREE

Report Highlights

  • U.S. market revenues for IV therapy and vein access were worth more than $4.6 billion in 2005. At an average annual growth rate (AAGR) of 4.2%, the market will reach almost $5.7 billion by 2010.
  • The market is broken down by ambulatory infusion pumps, enteral feeding pumps, peripheral venous access devices, and syringe infusion pumps. Ambulatory fusion pumps and peripheral venous access devices both held approximately 30% of the market share in 2005. Fusion pumps will maintain the majority of the market through the forecast period, holding a 29% share in 2010.
  • The fastest growing market sector will be syringe infusion pumps, which will have an AAGR of approximately 6.8% through the forecast period.

INTRODUCTION

The objectives of the study are to present a comprehensive look at the IV therapy device and vein access market. There are eight general categories of IV therapy:

  • ambulatory infusion pumps
  • central venous access devices
  • diabetes insulin infusion pump
  • enteral feeding pump and tubes
  • implantable pumps
  • large volume infusion pumps
  • peripheral venous access devices
  • syringe infusion pumps.
This BCC study is presented to increase the awareness of IV therapy devices and vein access. The study analyzes the IV therapy market from different standpoints and addresses issues and trends affecting IV therapy administration. IV therapy and vein access device manufacturers, driven by both research breakthroughs and increased recognition of expanding market opportunities, have stepped up the pace of development of innovative devices. Because of the evolving nature of this important area of medicine, executives of IV therapy devices must remain ever vigilant of the changing environment and strive to keep abreast of new and currently used modalities in all facets of IV therapy.

SCOPE OF STUDY

This report contains:

  • An in-depth look at the market for I.V. therapy and vein access in the United States market
  • An extensive overview of the industry, its relationship to the healthcare industry and its participants, and trends for the future
  • Competitive and market analyses, which historical data and market forecasts to 2010
  • Detailed company profiles of all the major players in the I.V. therapy and vein access industry.

METHODOLOGY AND INFORMATION SOURCES

The information and analysis presented in this BCC report are based on extensive first hand interviews with primary executives, product managers, and clinical specialists in the intravenous infusion and vein access arena. Background information was obtained from various government agencies, business and medical journals, trade magazines, and interviews with doctors and nurses involved in the administration of intravenous therapy and vein access.

Key information from published literature was used to conduct interviews with over 25 industry participants to validate and obtain expert opinions on current and future trends in the IV therapy and vein access industry. Interviews were the primary basis for development of market size. Interviews were also used to confirm and/or adjust market size and market share estimates, as well as formulating market projections.

All market data pertain to the U.S. market at the manufacturer's level. Data are expressed in current U.S. dollars. The base year was 2005. Historical data are provided for 2003 and 2004 and forecast data are provided for 2010. Historical, base year, and forecast data are provided for each market segment and subsegment. Market shares are provided for each market segment for the 2005 base year.
                              

ANALYST CREDENTIALS

Mary Anne Crandall has been publishing market research in the life sciences for more than 17 years. She holds a Master of Science Degree in psychology, and is the founder and CEO of Mountaintop Medical, LLC, a consulting firm in Oregon. She has taught at Southern Oregon University for more than 16 years, and before joining BCC's analytical team, she published with Frost & Sullivan, Theta Reports, FIND/SVP, MDI, FeedBack Research Services, Prognosis and Hall Enterprises. Ms. Crandall specializes in prescription pharmaceutical markets.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
 
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report